Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that doctors should carefully consider off-label drug use in dermatology and always inform patients, while more research is needed on the safety and effectiveness of such practices.

Several new treatments for different types of hair loss show promise in improving patient quality of life.

HIV can cause skin disorders, which are often the first sign of infection, especially in people with darker skin.

The review shows how to properly diagnose and treat the loss of eyebrow and eyelash hair.

Skin doctors should know about skin and kidney disease links to prevent serious kidney problems.

Early intervention with JAK inhibitors may prevent alopecia areata progression.

JAK inhibitors effectively and safely treat alopecia areata with few serious side effects.

The human microbiome is vital for health and can help treat diseases.

Caffeine shows promise for treating some types of hair loss, but more research is needed.

Pharmacists should interpret lab data and perform physical exams to improve patient care.

Young HS patients often have other physical and mental health issues, and research on HS covers a wide range of topics including genetics, triggers, treatments, and the need for more data.

Terbinafine can cause hair loss.

Nailfold dermoscopy is a simple, cheap way to check blood vessel changes in COVID-19 patients.

Tofacitinib and baricitinib are effective and safe for treating severe alopecia areata, especially in younger people.

More research is needed on alopecia areata treatments and its psychological effects.

JAK inhibitors, like baricitinib, are effective and safe for treating alopecia areata.

The article suggests that five common skin-related lab tests may be unnecessary and could cause extra cost and anxiety without improving patient care.

The book details skin conditions in older adults, their link to mental health, cancer treatment importance, hair loss remedies, and managing autoimmune and itchy skin.

Certain drugs may cause vitiligo, so patients should be monitored.

Total glucosides of paeony can help treat skin conditions but need more research for clinical use.

Upadacitinib significantly improved a man's severe scalp condition when other treatments failed.

New cytokine-targeted therapies show promise for treating alopecia areata.

Multiple treatment comparison meta-analyses help doctors make better decisions by comparing different interventions.

Hidradenitis Suppurativa is a chronic skin condition best treated early with surgery for better outcomes and less recurrence.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.

Apremilast may help treat lichen planopilaris and frontal fibrosing alopecia when other treatments fail.

Adalimumab is the most effective treatment for severe hidradenitis suppurativa, but more research is needed to improve treatment options.

Any drug can cause skin reactions, but antibiotics, NSAIDs, and psychotropic drugs are more common, with some reactions being life-threatening.

Upadacitinib effectively treated severe atopic dermatitis, vitiligo, and alopecia areata in one patient.

Ritlecitinib provides new treatment options for diverse alopecia areata patients.